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Abstract
Background: Chronic granulomatous disease (CGD) is an immune disorder that
affects phagocytes. It is characterized by recurrent or persistent bacterial and
fungal infections. Reports of tuberculosis (TB) in patients with CGD are rare. In
developing countries, where TB is endemic, possibility of other chronic infections
is often overlooked by physicians.
Case Description: We report the case of a 4‑year‑old boy who had recurrent
respiratory infections and episodes of headache. He was put on antituberculosis
(ATT) drugs without microbiological or pathological evidence 2 months prior to
presentation. The child did not improve and was brought to our hospital where
a computed tomography scan revealed multiple cerebral abscesses. These
abscesses were excised. The microbiological specimen was determined to
be positive for Aspergillus fumigatus. His tracheal aspirate was positive for
Mycobacterium tuberculosis polymerase chain reaction assay. Further work‑up
confirmed the diagnosis of CGD in the child.
Conclusion: This report describes the course of the patient’s illness in order to
highlight the challenges associated with the management of these infections. We also
aim to stress on the importance of pathological diagnosis before starting a therapy.
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INTRODUCTION
Chronic granulomatous disease (CGD) is a rare, primary
immunodeficiency disorder of phagocytes.[3] It is
characterized by repeated bacterial and fungal infections
with excessive inflammation and granuloma formation
in the skin, liver, lung, gastrointestinal tract, lymph
nodes, and bone. CGD has an incidence of 1 in
200,000–250,000 births,[8,9] and is usually diagnosed early
in infancy by nitroblue‑tetrazolium (NBT) negativity.
Fungal infections caused by Aspergillus species are an
important cause of morbidity and mortality in CGD.
Aspergillus fumigatus accounts for almost 78% of all
fungal infections, and is second only to Staphylococcus

aureus, which is the most frequent cause of infection in
patients with CGD.[9] The most common organs affected
by Aspergillus in CGD are the lungs; brain abscesses
secondary to Aspergillus are very rare.
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Although these patients have an increased susceptibility
to tuberculosis (TB), reports of TB in CGD are rare.[4,7]
In developing countries, where TB is endemic, there is
a tendency among physicians to treat patients without a
prior microbiological or pathological confirmation of the
diagnosis. This can lead to a delay in the diagnosis of
other potentially fatal infections. We describe this case
not only because the occurrence of cerebral aspergillosis
and pulmonary TB in CGD is rare but also to highlight
the merit of obtaining objective evidence before
embarking on a specific treatment plan.

CASE REPORT
A 4‑year‑old boy was brought to the Emergency
Department (ED) from a rural area with complaints
of fever, headache, and weight loss. He was suffering
from these symptoms for the past 4 months, which
had worsened in the past week. His brother informed
that the child had been unwell since infancy with
several episodes of respiratory infection and has had
several hospital admissions. Recently, he had started
complaining of severe persistent diffuse headaches along
with nausea, vomiting, and anorexia. He also suffered
from low grade fever intermittently over this period
of time. Physicians in his locality who had treated him
with antibiotic courses for chest infections started him
on antituberculosis (ATT) drugs 2 months back after an
MRI, which suggested meningeal enhancement and small
ring enhancing lesions. He had no history of seizures
or loss of consciousness. One of his brother had passed
away at the age of 8 years who was considered to suffer
from disseminated tuberculosis. On examination, the
child was listless, emaciated, and extremely irritable. He

a

b

c
Figure 1: (a) An axial contrast enhanced image of preoperative CT
brain showing multiple abscesses in the right parietooccipital area.
(b) A corresponding postoperative image showing no evidence of
residual. (c) Axial noncontrast enhanced CT scan brain at follow-up
showing gross hydrocephalus

http://www.surgicalneurologyint.com/content/7/1/62

had left‑sided weakness in both the upper and lower
extremities.
An urgent computed tomography (CT) scan of the head
showed multiple rings enhancing the left parietooccipital
region, with significant surrounding edema and mass
effect [Figure 1a]. His white blood cell count was
17900/uL, with neutrophils 77.4% and lymphocytes 15.7%.
Hemoglobin was 10.9 and erythrocyte sedimentation
rate (ESR) was 88 mm/h. We involved pediatric
physicians and infectious disease specialists to perform
a neuronavigation‑guided craniotomy for the excision of
these abscesses along with the walls, which contained
thick purulent material. Microscopic examination
revealed granulomas with fugal hyphae [Figure 2a and b].
Presence of Aspergillus was further confirmed on culture.
Postoperatively, he was successfully extubated and shifted
to the intensive care unit for postoperative monitoring.
His weakness also improved. Considering his chronic
cough and repeated chest infections, we obtained a
tracheal aspirate for examination, which was positive for
Mycobacterium tuberculosis polymerase chain reaction
assay. Considering the history, we screened the child
for immune deficiency disorders. Nitroblue‑tetrazolium
(NBT) was found to be negative, which established the
diagnosis of CGD.
Intravenous (IV) voriconazole was commenced at
6 mg/kg/dose every 12 h for 2–3 days, which was later
switched to 6 mg/kg/day orally. Five‑drug ATT treatment
was restarted for the management of pulmonary TB. He was
also given broad‑spectrum antibiotics. Pneumococcal and
meningococcal vaccines were administered as prophylaxis,
and co‑trimoxazole was included in the regimen for the
prevention of pneumocystis carinii pneumonia.
The child showed slow improvement, however, the
treatment course was complicated by fever, seizures, and
hyponatremia. Repeat CT scans did not show residual
or recurrent abscesses [Figure 1b]. After stabilization
of the medical condition, he was discharged. About
10 days after discharge, his family brought him to the
ED with complaints of drowsiness. CT scan showed
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Figure 2: (a) 10× magnification reveal chronic granulomatous
inflammation with central neutrophillic debri and multinucleated
giant cells. (b) Special periodic acid Schiff staining reveal septate
fungal hyphae; 40× magnification
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hydrocephalus [Figure 1c]. A temporary cerebrospinal
fluid (CSF) diversion was performed, followed by a
ventriculoperitoneal shunt once the CSF culture was
reported negative. The child was again discharged
after stabilization. He died 4 months later at home in
respiratory distress. The child could not be brought to us,
and hence no autopsy was performed to determine the
actual cause of his death.

DISCUSSION
CGD is a congenital disorder of the immune system,
which is characterized by impaired NADPH oxidase
activity of the phagocytes. This results in defective
intracellular killing of catalase‑positive microorganisms,
and clinically presents as recurrent, severe infections
usually in early infancy.[5,8] Although mycobacterium
is catalase positive, the case reports of Mycobacterium
tuberculosis are very few.
The child in our case presented with brain abscess caused
by Aspergillus fumigatus with pulmonary TB. Aspergillus
is a common pathogen in CGD patients, and most
commonly manifests as pulmonary complications or
as infections of the chest wall and bones. Neurological
complications, especially abscesses of the brain, are
uncommon and are rarely documented.[8] In fact, there
has been just one report of culture‑proven Aspergillus
brain abscess in a child with CGD.
Kolb et al. reported the case of a child suffering from
CGD along with pulmonary TB where Aspergillus brain
abscess was highly suspected, but was not proven on
microscopy or fungal culture. Another case was discussed
by Frank et al. where Aspergillus growth was proven
in culture and the child was successfully treated with
itraconazole and interferon.[5,7] In the present case, we
used voriconazole to treat the patient. The drug has been
shown to be efficacious against Aspergillus.[2]
Alsultan et al. reviewed literature on intracranial
abscesses in CGD and found four cases of intracranial
aspergillosis.[1] A case reported by Pollack et al. differed
from the current report in having epidural abscess and
skull osteomyelitis.[6] Three of the four cases reported
belonged to the pediatric age group whereas only two had
supratentorial Aspergillus abscesses. All the cases were
managed surgically, but with different antifungal agents.[1]
This case highlights several issues of medical and surgical
importance. In endemic areas, where incidence of TB
is very high, it is a common practice among physicians
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to start patients on ATT drugs on the basis of history,
examination, and nonspecific blood tests such as ESR.
This child had several key features in history to suggest
the possibility of an underlying immune disorder.
Important hints were not recognized and the diagnosis
had a significant delay. Another important point to
note from this case is the need for a close clinical and
radiological follow‑up because of the high risk of acute
hydrocephalus that warrants urgent surgical intervention.

CONCLUSION
Coexisting cerbral aspergillosis and pulmonary TB in
CGD is rare. Surgical excision of abscesses is essential to
reduce the mass effect as well as to establish a diagnosis.
However, these patients need prolonged antifungal drugs
and a close follow‑up because they are at a high risk
for the development of hydrocephalus and recurrence
of abscesses. This case also stresses on the fact that no
treatment should be offered to such patients without a
definite pathological diagnosis in the form of biopsy or
culture.
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